These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38181858)

  • 1. Natural products as pharmacological modulators of mitochondrial dysfunctions for the treatment of diabetes and its complications: An update since 2010.
    Lin QR; Jia LQ; Lei M; Gao D; Zhang N; Sha L; Liu XH; Liu YD
    Pharmacol Res; 2024 Feb; 200():107054. PubMed ID: 38181858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural products as pharmacological modulators of mitochondrial dysfunctions for the treatments of Alzheimer's disease: A comprehensive review.
    Jin X; Guo JL; Wang L; Zhong X; Yao WF; Gao H; Liu MY
    Eur J Med Chem; 2021 Jun; 218():113401. PubMed ID: 33831779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting AMPK in Diabetes and Diabetic Complications: Energy Homeostasis, Autophagy and Mitochondrial Health.
    Madhavi YV; Gaikwad N; Yerra VG; Kalvala AK; Nanduri S; Kumar A
    Curr Med Chem; 2019; 26(27):5207-5229. PubMed ID: 29623826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of AGEs formation by natural products.
    Nagai R; Shirakawa J; Ohno R; Moroishi N; Nagai M
    Amino Acids; 2014 Feb; 46(2):261-6. PubMed ID: 23504149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of silibinin in the management of diabetes mellitus and its complications.
    Chu C; Li D; Zhang S; Ikejima T; Jia Y; Wang D; Xu F
    Arch Pharm Res; 2018 Aug; 41(8):785-796. PubMed ID: 29978427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial remodelling-a vicious cycle in diabetic complications.
    Sherkhane B; Chayanika G; Sood A; Khatri DK; Singh SB
    Mol Biol Rep; 2021 May; 48(5):4721-4731. PubMed ID: 34023988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of disease: Mitochondrial dysfunction in sensory neuropathy and other complications in diabetes.
    Fernyhough P; McGavock J
    Handb Clin Neurol; 2014; 126():353-77. PubMed ID: 25410234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Mechanistic Review on Phytomedicine and Natural Products in the Treatment of Diabetes.
    Nanda J; Verma N; Mani M
    Curr Diabetes Rev; 2023; 19(7):e221222212125. PubMed ID: 36567295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic strategies for diabetes and complications: a role for sphingolipids?
    Fox TE; Kester M
    Adv Exp Med Biol; 2010; 688():206-16. PubMed ID: 20919656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of key molecular and pharmacological targets for diabetes and associated diseases.
    Shahcheraghi SH; Aljabali AAA; Al Zoubi MS; Mishra V; Charbe NB; Haggag YA; Shrivastava G; Almutary AG; Alnuqaydan AM; Barh D; Dua K; Chellappan DK; Gupta G; Lotfi M; Serrano-Aroca Á; Bahar B; Mishra YK; Takayama K; Panda PK; Bakshi HA; Tambuwala MM
    Life Sci; 2021 Aug; 278():119632. PubMed ID: 34019900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of diosgenin in diabetes and diabetic complications.
    Gan Q; Wang J; Hu J; Lou G; Xiong H; Peng C; Zheng S; Huang Q
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105575. PubMed ID: 31899316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research advances on astragaloside-IV in treatment of diabetes mellitus and its complications pharmacological effects].
    You LZ; Lin YX; Fang ZH; Shen GM; Zhao JD; Wang TT
    Zhongguo Zhong Yao Za Zhi; 2017 Dec; 42(24):4700-4706. PubMed ID: 29493134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remedying the Mitochondria to Cure Human Diseases by Natural Products.
    Mu JK; Li YQ; Shi TT; Yu LP; Yang YQ; Gu W; Li JP; Yu J; Yang XX
    Oxid Med Cell Longev; 2020; 2020():5232614. PubMed ID: 32733635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of natriuretic peptides in diabetes and its complications.
    Feng Y; Wang D; Bi H; Zhang H
    Biomed Pharmacother; 2016 Dec; 84():1826-1832. PubMed ID: 27832993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Compounds as Source of Aldose Reductase (AR) Inhibitors for the Treatment of Diabetic Complications: A Mini Review.
    Grewal AS; Thapa K; Kanojia N; Sharma N; Singh S
    Curr Drug Metab; 2020; 21(14):1091-1116. PubMed ID: 33069193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogen Sulfide in Diabetic Complications Revisited: The State of the Art, Challenges, and Future Directions.
    Sun HJ; Xiong SP; Wang ZC; Nie XW; Bian JS
    Antioxid Redox Signal; 2023 Jan; 38(1-3):18-44. PubMed ID: 36310428
    [No Abstract]   [Full Text] [Related]  

  • 18. Research progress of coumarins and their derivatives in the treatment of diabetes.
    Pan Y; Liu T; Wang X; Sun J
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):616-628. PubMed ID: 35067136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review on protective role of genistein against oxidative stress in diabetes and related complications.
    Weng L; Zhang F; Wang R; Ma W; Song Y
    Chem Biol Interact; 2019 Sep; 310():108665. PubMed ID: 31125535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of natural products against myocardial ischemia/reperfusion: Mitochondria-targeted therapeutics.
    Su X; Zhou M; Li Y; Zhang J; An N; Yang F; Zhang G; Yuan C; Chen H; Wu H; Xing Y
    Biomed Pharmacother; 2022 May; 149():112893. PubMed ID: 35366532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.